University of Aberdeen Leads World-First Brain Health MRI Study with FCI Technology

🧠 Aberdeen's Pioneering Push in Brain Health Research

The University of Aberdeen is once again making headlines in medical imaging with the launch of a groundbreaking brain health study that leverages advanced MRI technology. This world-first initiative, building on the university's storied legacy in MRI innovation, aims to detect the earliest signs of declining brain health using Field-Cycling Imaging (FCI), a novel low-field MRI technique developed right in Aberdeen. Researchers at the University of Aberdeen are focusing on cerebral small vessel disease (SVD), a common age-related condition that silently contributes to strokes and dementia, affecting millions worldwide but often going undetected until it's too late.

Cerebral small vessel disease involves damage to the tiny blood vessels deep within the brain, leading to white matter hyperintensities visible on scans and cognitive impairments over time. By employing FCI, which uniquely switches between ultra-low and low magnetic fields, the study promises to reveal subtle changes that standard high-field MRI scanners miss. This could revolutionize early intervention strategies, allowing clinicians to identify at-risk individuals before symptoms emerge.

The project's timely launch comes amid rising concerns over aging populations in the United Kingdom, where dementia cases are projected to exceed one million by 2030. Aberdeen's expertise positions it as a leader in addressing these challenges through higher education-driven research.

The Storied Legacy of MRI at the University of Aberdeen

The University of Aberdeen's contributions to magnetic resonance imaging (MRI) date back nearly 50 years, when Professor John Mallard and his team designed and built the world's first full-body clinical MRI scanner in the late 1970s and early 1980s. Demonstrated with patients from NHS Grampian, this invention has since saved millions of lives globally by enabling non-invasive imaging of the body's soft tissues.

Today, that pioneering spirit lives on in the Biomedical Imaging Centre (ABIC) and the Centre for Adaptable Imaging Technologies. Facilities house state-of-the-art equipment, including the next-generation FCI scanner, which builds directly on MRI principles but operates at much lower field strengths—typically below 0.2 Tesla compared to the 1.5-3 Tesla of conventional systems. This allows for unprecedented sensitivity to tissue properties affected by disease.

Recent advancements, such as low-field MRI developments by Research Postgraduate Gabriel Zihlmann and Dr. Mathieu Sarracanie, are integral to the study, testing whether FCI insights can translate to more affordable, portable scanners suitable for widespread clinical use.

Unpacking Cerebral Small Vessel Disease: A Silent Threat

Cerebral small vessel disease (SVD), also known as small vessel ischemic disease, refers to pathological changes in the brain's smallest arteries, arterioles, capillaries, venules, and small veins. These alterations lead to reduced blood flow, oxygen deprivation, and buildup of waste products, manifesting as white matter hyperintensities, lacunar infarcts, and microbleeds on imaging.

In the UK, SVD underlies about 45% of ischemic strokes and contributes to up to 20% of dementia cases, with prevalence increasing sharply after age 65—over 90% of people over 80 show some signs. Risk factors include hypertension, diabetes, smoking, and high cholesterol, but progression varies widely, making early detection crucial.

• White matter hyperintensities: Bright spots on T2-weighted MRI indicating demyelination or gliosis.
• Lacunar strokes: Small cavities from vessel occlusion.
• Perivascular spaces enlargement: Fluid-filled spaces around vessels signaling impaired clearance.
• Microbleeds: Tiny hemorrhages detectable on susceptibility-weighted imaging.

Current diagnostics rely on high-field MRI, which is costly (machines exceed £1 million) and inaccessible in many areas. Aberdeen's study addresses this gap head-on.

How Field-Cycling Imaging Works: A Step-by-Step Breakdown

Field-Cycling Imaging (FCI), pioneered at Aberdeen, enhances MRI by dynamically varying the magnetic field strength during the scan. Here's how it operates:

1. Relaxation phase: The sample is polarized at a high field (e.g., 1 Tesla) to align nuclear spins.
2. Cycling phase: Field rapidly switches to ultra-low (e.g., 0.01 Tesla) or low levels, allowing measurement of relaxation times (T1 dispersion) sensitive to molecular dynamics.
3. Acquisition: Signal detected at a stable low field, capturing unique tissue signatures invisible at fixed high fields.
4. Analysis: AI-driven processing extracts biomarkers like R1 dispersion curves for SVD markers.

This process, impossible with standard MRI, reveals protein dynamics and water interactions altered by SVD, offering superior contrast for early pathology. Previous PUFFINS2 results confirmed FCI detects moderate-to-severe SVD reliably.

For patients, scans are safe, non-invasive, and shorter than traditional MRI, with no ionizing radiation.

Inside the PUFFINS Brain Health Study: Team, Methods, and Funding

The PUFFINS Brain Health Study (PUFFINS-BH), formally "Proving the Utility of Field Cycling Imaging in Small Vessel Disease – a focus on Brain Health," is sponsored by the University of Aberdeen (NCT06947876).ClinicalTrials.gov Co-led by Dr. Gordon Waiter (ABIC Director), Prof. Mary Joan MacLeod (Institute of Medical Sciences Chair), and Dr. Nicholas Senn, it integrates physics, computer science, and clinical expertise.

Funded with £349,956 from the Scottish Government Chief Scientist Office and NHS Grampian Charity, the study recruits from North East Scotland via Scottish Brain Sciences' IONA Cohort. Participants undergo FCI, low-field MRI, and cognitive assessments to track SVD progression longitudinally.

"With people living longer, understanding earliest declining brain health is pressing," says Dr. Waiter.

From PUFFINS to PUFFINS-BH: Evolutionary Success

Building on PUFFINS and PUFFINS2, which validated FCI for stroke and SVD using prior-generation scanners, PUFFINS-BH employs upgraded hardware for finer early-stage detection. Early data showed FCI's edge in quantifying white matter changes.

This progression exemplifies Aberdeen's commitment to iterative innovation, from proof-of-concept to clinical translation.

Human Stories: Volunteers Powering the Research

John Heatherill, an electronics engineer who worked on early Aberdeen MRI systems alongside Prof. Mallard, was among the first volunteers. "When I received the letter... I just had to volunteer," he shared, bridging past and future innovations.

Community involvement underscores the 'triple helix' model: university, NHS, and industry collaboration via Scottish Brain Sciences.

Transformative Implications for Stroke and Dementia Prevention

By enabling pre-symptomatic SVD detection, PUFFINS-BH could slash stroke incidence—SVD causes 25% of UK strokes annually—and delay dementia onset. Early interventions like blood pressure control or lifestyle changes might preserve brain function.HRA Summary

• Personalized risk stratification for high-risk groups.
• Cost savings: Low-field tech reduces scanner costs by 80%.
• Broader access in rural Scotland.

Prof. MacLeod envisions routine screening: "...make it easier to screen and identify... at risk of developing dementia."

Scotland's Triple Helix: Fostering Higher Ed Research Excellence

The study exemplifies partnerships: University of Aberdeen, NHS Grampian, Scottish Brain Sciences at BioHub Aberdeen. Prof. Craig Ritchie hails it as "triple helix in action." Such models boost UK higher education's impact.Academic career advice for aspiring researchers.

Toward Portable MRI: Future Horizons in Neuroimaging

Transferring FCI biomarkers to fixed low-field MRI promises backpack-sized scanners for GP clinics or homes, democratizing brain health monitoring. Ongoing Aberdeen work in AI analysis accelerates this vision.

Globally, this aligns with UKRI priorities for aging research, potentially influencing policy and funding.

Careers in Neuroimaging: Opportunities at Aberdeen and Beyond

The University of Aberdeen seeks talent in imaging physics and data science. Roles in research assistant jobs and research positions offer hands-on FCI experience. Rate professors like Dr. Waiter on Rate My Professor for insights.

For career advice, visit higher ed career advice.

Photo by Polka w UK on Unsplash

A New Era for Brain Health Research

Aberdeen's PUFFINS-BH study heralds a transformative era, leveraging higher education innovation to safeguard brain health. Explore higher ed jobs, university jobs, or rate your professors to engage further. Stay informed on UK research breakthroughs.

Thrive in research roles.